ISPE CEUs: 1.3
Type: Classroom Training Course
With the increasing regulatory scrutiny on combination products this new highly interactive course provides six (6) different aspects of a combination product which are:
An overview and the intricacies of the GMPs for combination products will be provided that specifically address the challenges and expectations from industry and global regulatory agencies. The development of the basis for the product, testing, and specifications including identifying design inputs, user requirements and design requirements as starting points to the development process will be reviewed in detail.
The course will also include how to test and how to determine the appropriate level of design validation for combination products, which has been a hot topic recently for regulatory bodies. Discussions and interactive sessions for the application of proper design of validation studies, which is critical to assuring that your customers are satisfied and can appropriately use your combination products, will be explored to provide insights into the development for designing validation studies. Additional content will address key questions regarding establishment of appropriate studies to assure that user requirements have been met.
Designing and executing a clinical trial for combination products, which often presents unique challenges, will be explored. To support the market authorization for a combination product, identifying common questions surrounding clinical trial design including sample size requirements, number and extent of clinical studies required, as well as claims that may be made based on the trials will be discussed. Case studies for use of drug delivery systems will be provided for an in-depth review.
Human Factors studies are an integral component of product development for most combination products today. This course will discuss the special considerations for designing formative and summative human factors studies for combination products, including unique user group requirements and how they are defined (elderly, visually impaired, pediatrics), sample size, and environmental use conditions. Course participants will review the US FDA’s perspective into common issues and challenges as well as how to address them, and how to best present the information.
Participants should be prepared to work in groups to prepare and organize human factors study data in preparation for a regulatory submission to facilitate a timely US FDA review.
The course will also consider the role of post-marketing safety surveillance and other design corrective and preventive action inputs in product design evolution and validation during the life-cycle of a device containing combination product.
Individuals working with Operations, Regulatory Affairs, Clinical Affairs, Manufacturing, Quality, Product and Process Development Engineering, and Project Management professionals.
This training course is of particular interest to existing and future members of the ISPE Product and Process Development Communities of Practice (COPs).
ISPE will provide continuing education units (ISPE CEUs) for all North American seminars and courses, including educational programming at the ISPE Annual Meeting. CEUs are nationally recognized units of achievement designed for those individuals continuing their education in their chosen field or profession.
Delegates attending European seminars and courses will receive a Certificate of Attendance, as ISPE CEUs are currently not offered at European events. Verification of CEUs is based on attendance as well as satisfactory completion of all evaluation materials. Statements of credit will be available for download in your ISPE account a within four weeks of the completion of training. Instruction for download will be sent when the CEUs are available. One hour of education programming equals 0.1 ISPE CEU credits.